Psoriasis Area and Severity Index (PASI Score)
Showing 1 - 25 of >10,000
PASI Scoring Using Digital-Based Images
Not yet recruiting
- Plaque Psoriasis
- In-Person and Remote Disease Assessment
- (no location specified)
Apr 18, 2023
Secukinumab in Patients With Moderate to Severe Plaque Psoriasis
Completed
- Plaque Psoriasis
- Secukinumab
-
East Hanover, New JerseyNovartis Investigative Site
Jun 29, 2022
Psoriasis Vulgaris Trial in Surabaya (Lactobacillus Plantarum IS-10506, Placebo)
Recruiting
- Psoriasis Vulgaris
- Lactobacillus Plantarum IS-10506
- Placebo
-
Surabaya, Jawa Timur, IndonesiaUniversitas Airlangga
Feb 15, 2022
Psoriasis, Vitamin D Deficiency Trial in Tromsø (25-Hydroxyvitamin D, Placebo oral capsule)
Completed
- Psoriasis
- Vitamin D Deficiency
- 25-Hydroxyvitamin D
- Placebo oral capsule
-
Tromsø, NorwayUniversity Hospital of North Norway
Oct 7, 2020
Moderate-to-Severe Plaque Psoriasis Trial in Shenyang (Jaktinib, Placebo)
Recruiting
- Moderate-to-Severe Plaque Psoriasis
- Jaktinib
- Placebo
-
Shenyang, Liaoning, ChinaThe First Affiliated Hospital of China Medical University
Nov 28, 2022
Simplified Severity Score in Bullous Pemphigoid
Not yet recruiting
- Bullous Pemphigoid
- IGA score
- BULLOUS PEMPHIGOID DISEASE AREA INDEX (BPDAI)
-
Bordeaux, France
- +10 more
May 4, 2022
Moderate-to-severe Plaque Psoriasis Patients Response to
Completed
- Moderate-to-severe Plaque Psoriasis
-
Jakarta, IndonesiaMangga Besar Clinic
Mar 15, 2023
Plaque Psoriasis Trial in Budapest, Hévíz (balneotherapy)
Recruiting
- Plaque Psoriasis
- balneotherapy
-
Budapest, Hungary
- +1 more
Jun 22, 2022
The Disease Severity In Patients With Psoriasis
Completed
- Psoriasis
-
Sukoharjo, Central Java, IndonesiaUniversitas Sebelas Maret Hospital
Jul 4, 2023
Psoriasis Vulgaris Trial (SDD formula, Placebo)
Not yet recruiting
- Psoriasis Vulgaris
- SDD formula
- Placebo
- (no location specified)
Apr 4, 2023
Disease State When Subcutaneous Risankizumab Injection is Given
Recruiting
- Psoriasis
-
Taichung City, Taiwan
- +1 more
May 19, 2022
Chronic Plaque Psoriasis Trial in Canada, United States (ARQ-151 0.3% cream, ARQ-151 vehicle cream)
Completed
- Chronic Plaque Psoriasis
- ARQ-151 0.3% cream
- ARQ-151 vehicle cream
-
Scottsdale, Arizona
- +38 more
Dec 5, 2022
Tolerability in Pediatric Patients With Psoriasis
Not yet recruiting
- Moderate-to-severe Plaque Psoriasis
- Secukinumab
- (no location specified)
Nov 16, 2023
Psoriasis Trial in Shanghai (HS-10374 tablets 1mg, HS-10374 tablets 5mg, HS-10374-matched tablets)
Not yet recruiting
- Psoriasis
- HS-10374 tablets 1mg
- +2 more
-
Shanghai, Shanghai, ChinaHuashan Hospital of Fudan University
Oct 8, 2023
Chronic Plaque Psoriasis Trial in Canada, United States (ARQ-151 0.3% cream, ARQ-151 vehicle cream)
Completed
- Chronic Plaque Psoriasis
- Roflumilast 0.3% cream
- Vehicle Cream
-
Encinitas, California
- +39 more
Dec 5, 2022
Plaque Psoriasis Trial in China (Jiuweihuaban Pill , low dose Jiuweihuaban Pill, high dose Jiuweihuaban Pill)
Not yet recruiting
- Plaque Psoriasis
- Jiuweihuaban Pill placebo
- +2 more
-
Beijing, China
- +11 more
Sep 27, 2023
Psoriasis Trial (Inflammatory skin disease formula, Placebo)
Not yet recruiting
- Psoriasis
- Inflammatory skin disease formula
- Placebo
- (no location specified)
Oct 18, 2022
Moderate to Severe Chronic Plaque-type Psoriasis Trial in Worldwide (secukinumab low dose, secukinumab high dose)
Active, not recruiting
- Moderate to Severe Chronic Plaque-type Psoriasis
- secukinumab low dose
- secukinumab high dose
-
Fountain Valley, California
- +22 more
Dec 24, 2022
Plaque Psoriasis Trial (Mind.Px Report)
Not yet recruiting
- Plaque Psoriasis
- Mind.Px Report
- (no location specified)
Sep 13, 2021
Psoriatic Arthritis, Psoriasis Trial in Avignon (Fatigue assessment, Quality of life assessment, Assess severity of psoriatic
Not yet recruiting
- Psoriatic Arthritis
- Psoriasis
- Fatigue assessment
- +3 more
-
Avignon, Provence-Alpes-Côte d'Azur, FranceCentre Hospitalier d'Avignon
Oct 20, 2023
Psoriasis, Alopecia Areata, Polymorphous Light Eruption Trial (Lumiton yarn sleeve, Lumiton yarn hat, Lumiton yarn shirt)
Recruiting
- Psoriasis
- +2 more
- Lumiton yarn sleeve
- +2 more
-
Winston-Salem, North CarolinaWake Forest University Health Sciences, Dermatology
Dec 21, 2022